PPT-Non-Invasive Testing for Liver Fibrosis

John Scott MD MSc Associate Professor University of Washington Associate Clinic Director Hep Liver Clinic Harborview Presentation prepared by John Scott MD MSc Sanjeev Arora MD Paula CoxNorth PhD. Mamta K. Jain, MD, MPH. What are the indications for a liver biopsy?. Diagnosis of liver disease. Assess severity of liver disease. Assess response to treatment. Hepatitis B. I. nitial trials used pre-treatment and post-treatment biopsy to assess response to nucleoside therapy. Co-Infected . Adults. Jayaweera. DT, . Campa. A, . Casillas. VJ, Martinez SS, Shin DH, Li Y, Young S, Baum MK. Background. P. atients co-infected with HIV/HCV compared. . to those infected with. . By.  . Dr. . Eman. . Gamal. El-Din . El-. Ahwany. Professor . of Immunology. Immunology Department. Theodor . Bilharz. Research Institute.  . 3. rd. Congress of Hepatitis and Liver Diseases October 10-12, 2016 Dubai, UAE. HCV: . From Diagnosis . to Cure. to Elimination . HCV 101. What you really need to know. Workflow. Diagnosis. Lab/Imaging workup. Fibrosis Staging. Critical Information that guides treatment. Treatment Plan and follow-up. Fatty Liver Disease. Anna Christina Dela Cruz, MD. Division of Digestive Diseases and Nutrition . Conflict of Interest. None. Upon completion of this activity, participants will be able to: . Select appropriate diagnostic testing for the evaluation of gastrointestinal comorbidities in patients with diabetes.. Moderator. Kris V. Kowdley, MD . Director . Liver Institute Northwest . Clinical Professor. Elson S. Floyd College of Medicine. Washington State University. Seattle, Washington . Overview of Discussion. Hepatologist. East & North Hertfordshire NHS Trust. Royal Free London NHS Foundation Trust. ELF Research Group. University College London. Liver disease. Scale of the problem. Liver disease is the 5. A. . Ansari. Deptt. . Of Pathology. JNMC,AMU. Fatty liver. Gross Description. Fatty liver is caused by the excessive deposition of fats, especially triglycerides, in the cells of the liver.. The liver appears enlarged and pale/yellowish in . Oluwatoyin ( . Toyin. ) Adeyemi, MD. Director, CORE Viral hepatitis Clinic. Senior director for HIV services, Cook County Health . Triple Threat 11: HIV, HCV & . Opiods. Dusable. Museum , June 25, 2019. oligoribonucleotides. -D-mannitol complexes against thioacetamide-induced liver fibrosis. Tetiana Marchyshak. 1. , Larisa Semernikova. 1. ,. . Tetiana Yakovenko. 1. and Zenoviy Tkachuk. 1,. *. 1. Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine 150, . Best of ILC 2018. About these slides. These slides provide highlights of new data presented at the International Liver Congress 2018. Please feel free to use, adapt, and share these slides for your own personal use; however, please acknowledge EASL as the source. Martin H. 1. , . Martinez SS. 1. , . Stebliankin. V. 2. , . Tamargo. J. 1. , Campa A. 1. , Narasimhan G. 2. , Baum MK. 1. Florida International University, Department of Dietetics and Nutrition, Miami, FL, United States. Malattie dell’Apparato Digerente. Tutor: Prof. Alessandro Federico. 20-33% in adulti-anziani. :. Incrementa con l’età;. Più alta negli uomini rispetto alle donne;. Più alta nei soggetti di etnia caucasica rispetto agli ispanici;. 2. , Revital Aricha. 2. , Ilan Vaknin. 2. , Scott Friedman. 3. , Adi Mor. 2. 1. Hadassah Hebrew University Hospital, Israel, . 2. Chemomab Therapeutics, Ltd, United States, . 3. Icahm School of Medicine, United States.